SCHEMBL11484366

SCHEMBL11484366

O=C1CCCC(c2ccccc2)C1c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 3/20 0.44
ALOX5 P09917 3/20 0.44
SLC18A3 Q16572 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MCL1 Q07820 1/20 0.40
SLC6A3 Q01959 1/20 0.39
MAPT P10636 1/20 0.39
CREBBP Q92793 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
CYP2C19 P33261 2/20 0.38
KDM1A O60341 1/20 0.38
CYP2B6 P20813 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11476638 0.90 SLC6A2 (0.40) MT-CO2ALOX5KMT2ASLC6A3LMNA
SCHEMBL28474134 0.80 CYP1A2 (0.43) MEN1KMT2AALDH1A1ALOX15MAPT
SCHEMBL28477779 0.79 MT-CO2 (0.43) MT-CO2ALOX5SLC18A3MEN1KMT2A
SCHEMBL11473867 0.79 MT-CO2 (0.43) MT-CO2ALOX5SLC18A3MEN1KMT2A
SCHEMBL24820969 0.79 MT-CO2 (0.43) MT-CO2ALOX5SLC18A3MEN1KMT2A
SCHEMBL24806685 0.79 MT-CO2 (0.43) MT-CO2ALOX5SLC18A3MEN1KMT2A
SCHEMBL23256884 0.79 MCL1 (0.42) SLC18A3ALDH1A1TSHRMCL1MAPT
SCHEMBL11475259 0.79 SLC18A3 (0.41) MT-CO2ALOX5SLC18A3KMT2AALDH1A1
SCHEMBL10298882 0.79 SLC6A3 (0.41) MEN1KMT2ASLC6A3MAOBLMNA
SCHEMBL10281610 0.79 SLC6A3 (0.39) ALDH1A1SLC6A3MAPTMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109908-A1 METHOD FOR CARRYING OUT REACTION OF ISATIN COMPOUND AND CYCLOPROPENONE COMPOUND AT LOW CATALYTIC AMOUNT SOOCHOW UNIVERSITY (CN) 2024-04-04 US disclosed
US-4187152-A Extractive distillation for separating ketones and/or alcohols from phenol and/or cresol ALLIED CHEMICAL CORPORATION (US) 1980-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109908-A1 METHOD FOR CARRYING OUT REACTION OF ISATIN COMPOUND AND CYCLOPROPENONE COMPOUND AT LOW CATALYTIC AMOUNT INMT, PPIP5K2, HASPIN MT-CO2 2805/4885ALOX5 685/4885SLC18A3 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.